- Approval Id
- 844547d15c38012b
- Drug Approval Philippines Name
- Cervarix
- Product Name
- Cervarix
- Registration Number
- BR-783
- Brand Name
- Cervarix
- Generic Name
- Human Papillomavirus Vaccine [Types 16 and 18]
(Recombinant, adjuvanted, adsorbed)
- Dosage Form
- Suspension for Injection (IM)
- Dosage Strength
- Formulation: 1 dose (0.5 mL) contains: Human Papillomavirus type 16 Ll protein*..............20 mcg Human Papillomavirus type 18 L1 protein*... ...........20 mcg
*adjuvanted by AS04 containing 3-O-desacyl-4-monophosphoryl lipid A (MPL) and Aluminum hydroxide, hydrated [Al(OH)3]
- Manufacturer
- GlaxoSmithKline Biologicals SA
- Importer
- GlaxoSmithKline Philippines, Inc.
- Distributor
- GlaxoSmithKline Philippines, Inc.
- Company Detail Path
- /organization/glaxosmithkline-biologicals-sa
- Issuance Date
- 27 April 2022
- Expiry Date
- 23 March 2027
- Classification
- Prescription Drug (RX)
